BETA-LACTAMASES OF MORAXELLA-CATARRHALIS

被引:6
|
作者
CULLMANN, W
机构
[1] F. Hoffmann-La Roche Ltd, CH 4002 Basel
来源
MEDECINE ET MALADIES INFECTIEUSES | 1992年 / 22卷
关键词
MORAXELLA-CATARRHALIS; BETA-LACTAMASES; SENSITIVITY TO ANTIBIOTICS; CLINICAL RELEVANCE OF BETA-LACTAMASES; OUTER MEMBRANE PROTEINS;
D O I
10.1016/S0399-077X(05)80865-0
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The enzymes called BRO-1 (formerly called "Ravasio-type") and BRO-2 (formerly called "1908-type") are the most predominantly observed beta-lactamases in clinical Moraxella catarrhalis isolates. Both of these enzymes can be observed on a worldwide scale, whereas other enzymes occur infrequently. The first beta-lactamase producing (bla+) isolate was detected in clinical specimens in 1976; at present however, 70 to 90 % of all clinical isolates are bla+. These enzymes are most likely transposon-mediated and can be observed in other members of the Moraxella family. The molecular weight ot the BRO-1 enzyme amounts to 33 kdal; it hydrolyses the penicillin derivatives very rapidly, to a lesser extent the older cephalosporins; however, the latter ones exhibit low affinity to the enzyme.
引用
收藏
页码:529 / 534
页数:6
相关论文
共 50 条
  • [31] DETECTION, DISTRIBUTION AND INHIBITION OF BRANHAMELLA-CATARRHALIS BETA-LACTAMASES
    PHILIPPON, A
    RIOU, JY
    GUIBOURDENCHE, M
    SOTOLONGO, F
    DRUGS, 1986, 31 : 64 - 69
  • [32] LABILE TYPE-SPECIFIC ANTIGEN OF MORAXELLA-CATARRHALIS
    NORKUS, SJ
    VENNES, JW
    JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (12) : 2815 - 2817
  • [33] EVIDENCE FOR LECTIN-MEDIATED ADHERENCE OF MORAXELLA-CATARRHALIS
    KELLENS, J
    PERSOONS, M
    VANEECHOUTTE, M
    VANTIEL, F
    STOBBERINGH, E
    INFECTION, 1995, 23 (01) : 37 - 41
  • [34] CLINICAL, DIAGNOSTIC AND THERAPEUTIC ASPECTS OF MORAXELLA-CATARRHALIS INFECTIONS
    BOURGEOIS, F
    LAMBERTZECHOVSKY, N
    BINGEN, E
    PATHOLOGIE BIOLOGIE, 1993, 41 (06): : 555 - 561
  • [35] MORAXELLA-CATARRHALIS - ANTIBIOTIC SUSCEPTIBILITY WITH SPECIAL REFERENCE TO TRIMETHOPRIM
    WINSTANLEY, TG
    SPENCER, RC
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 (03) : 425 - 426
  • [36] Antimicrobial resistance and production of beta-lactamases in Bulgarian clinical isolatesMoraxella catarrhalis
    Raina Gergova
    Rumyana Markovska
    Ivan Mitov
    Annals of Microbiology, 2009, 59 : 169 - 172
  • [37] USE OF API NH SYSTEM FOR IDENTIFICATION OF MORAXELLA-CATARRHALIS
    PEIRIS, V
    BENNETT, C
    NORRIS, S
    JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (10) : 2628 - 2628
  • [38] EPIDEMIOLOGIC TYPING OF MORAXELLA-CATARRHALIS BY USING DNA PROBES
    BEAULIEU, D
    SCRIVER, S
    BERGERON, MG
    LOW, DE
    PARR, TR
    PATTERSON, JE
    MATLOW, A
    ROY, PH
    JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (03) : 736 - 739
  • [39] PULMONARY CLEARANCE OF MORAXELLA-CATARRHALIS IN AN ANIMAL-MODEL
    UNHANAND, M
    MACIVER, I
    RAMILO, O
    ARENCIBIAMIRELES, O
    ARGYLE, JC
    MCCRACKEN, GH
    HANSEN, EJ
    JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (04): : 644 - 650
  • [40] SUSCEPTIBILITY OF MORAXELLA-CATARRHALIS ISOLATES TO BETA-LACTAM ANTIBIOTICS IN RELATION TO BETA-LACTAMASE PATTERN
    FUNG, CP
    YEO, SF
    LIVERMORE, DM
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (02) : 215 - 222